PUBLICATIONS

 
Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies

Chloé Wyndham-Thomas, Leonie de Munter, Kok Yew Ngew, Sanskruti Gaikwad, Konstantina Chatzikonstantinidou, Antonio Carmona, Charlotte Martin, Gerrit Luit ten Kat, Nicolas Praet, Wilhelmine Meeraus, Matthew D. Rousculp, and Kaatje Bollaerts

Vaccines (2025)
https://doi.org/10.3390/vaccines13101047

Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study.

Chloé Wyndham-Thomas, E. Claire Newbern, Ainara Mira-Iglesias, Akshat Dwivedi, Alejandro Orrico Sánchez, Andrés Antón, Charlotte Martin, Giancarlo Icardi, Irma Casas, Kok Yew Ngew, Laura Drikite, Leonie de Munter, Gerrit Luit ten Kate, Nikki Vroom, Sebastian Baumgartner, Susana Otero-Romero, Xavier Holemans, Kaatje Bollaerts, and Nicolas Praet

Journal of Infection and Public Health (2025)
https://doi.org/10.1016/j.jiph.2025.102700

Effectiveness of the AZD1222 Vaccine against COVID-19 hospitalisation in Europe: Final results from the COVIDRIVE test-negative case-control study. 

Leonie de Munter, Wilhelmine Meeraus, Akshat Dwivedi, Marianna Mitratza, Chloé Wyndham-Thomas, Lucy Carty, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet Rebry, Irma Casas, Ainara Mira-Iglesias, Giancarlo Icardi, Susana Otero-Romero, Sebastian Baumgartner, Charlotte Martin, Xavier Holemans, Gerrit Luit ten Kate, Kaatje Bollaerts, and Sylvia Taylor.

European Journal of Public Health (2025)
https://doi.org/10.1093/eurpub/ckae219

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVEplatform.

Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, Leonie de Munter, Thao Mai Phuong Tran, Catia Marques, Mustapha Mustapha, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma Casas, Eduardo Conde-Sousa, Laura Drikite, Beate Grüner, Giancarlo Icardi, Gerrit Luit ten Kate, Charlotte Martin, Ainara Mira-Iglesias, Alejandro Orrico-Sánchez, Susana Otero-Romero, Gernot Rohde, Luis Jodar, John M. McLaughlin, and Kaatje Bollaerts. Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform.

eClinicalMedicine (2025),
https://doi.org/10.1016/j.eclinm.2024.102995

Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.

Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, Akshat Dwivedi, Chloé Wyndham-Thomas, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet Rebry, Antonio Carmona, Anke L. Stuurman, Thi Yen Chi Nguyen, Guillermo Mena, Ainara Mira-Iglesias, Giancarlo Icardi, Susana Otero-Romero, Sebastian Baumgartner, Charlotte Martin, Sylvia Taylor, and Kaatje Bollaerts. Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.

The Lancet Regional Health – Europe (2023), 
https://doi.org/10.1016/j.lanepe.2023.100675

Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform” (pre-print).

HR Volkman, L de Munter, JL Nguyen, TMP Tran, M Mitratza, C Marques, L Choi, S Valluri, J Yang, A Antón, I Casas, E Conde-Sousa, L Drikite, B Grüner, G Icardi, G Luit ten Kate, C Martin, A Mira-Iglesias, A Orrico-Sánchez, S Otero-Romero, G Rohde, L Jodar, JM McLaughlin, K Bollaerts.

MedRxiv (2025) – preprint
https://doi.org/10.1101/2025.05.02.25326904

The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative

Díez-Domingo J, Torcel-Pagnon L, Carmona A, Launay O, Dos Santos G, Rizzo C, Haag M, Stuurman A, Nauta J, Vannacci A, de Lusignan S, Del Rey E, Levi M, Lina B, Bellino S, Nye S, Neels P, Nohynek H, Mahé C; DRIVE consortium. 

Expert Rev Vaccines. 2022 Dec;21(12):1701-1710. doi: 10.1080/ 14760584.2022.2137144. PMID: 36261918.
https://www.tandfonline.com/doi/10.1080/14760584.2022.2137144?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed